Galea Therapeutics
PrivateCompany Overview
Galea Therapeutics is a biotechnology company that develops small molecule drugs for the treatment of fatty liver disease and related metabolic conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Galea Therapeutics Comparables
Compare Galea Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NorthSea Therapeutics | 83% | |
| Inventiva S.A. | 81% | |
| Terns Pharmaceutical | 79% |
Galea Therapeutics Funding Rounds
Historical fundraising activity
Galea Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Galea Therapeutics's valuation, stock price, and market status.
Is Galea Therapeutics a public or private company?
Galea Therapeutics is a private company.
What is the current stock price of Galea Therapeutics?
Galea Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Galea Therapeutics worth (valuation)?
Galea Therapeutics's valuation is estimated at $777.3M based on funding round data.
Can I buy Galea Therapeutics stock?
Galea Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Galea Therapeutics's last funding round?
Galea Therapeutics's most recent funding round was Private Equity on April 14, 2026.
Who are the main investors in Galea Therapeutics?
Key investors in Galea Therapeutics include Novo Ventures, BioGenerator Ventures, Blackstone Life Sciences, New Enterprise Associates.
Will Galea Therapeutics IPO soon?
No public IPO plans have been announced for Galea Therapeutics.
How can I track Galea Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Galea Therapeutics's secondary market activity and sign up for updates.